Hims vs MangoRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats MangoRx overall, scoring 7.9/10 vs 7.5/10. Hims is more affordable at $175/mo vs $299/mo. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose MangoRx for users who want a multi-service telehealth platform covering .
A side-by-side comparison of Hims and MangoRx covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit HimsMangoRx
#23 of 40Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRx| Feature | Hims | MangoRx |
|---|---|---|
| Our Score | 7.9/10 | 7.5/10 |
| Starting Price | $175/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want a multi-service telehealth platform covering weight loss and men's health |
| Ranking | #12 | #23 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
MangoRx
Pros
- +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
- −Early-stage public company with limited revenue — stock performance reflects financial uncertainty
- −Only oral tablet format available — no injectable options if you want higher bioavailability
Our Verdict
Hims edges out MangoRx with a score of 7.9/10 vs 7.5/10. If budget is your priority, Hims starts at $175/mo compared to MangoRx's $299/mo. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health.